The 6 analysts offering 12-month price forecasts for Anavex Life Sciences Corp have a median target of 37.00, with a high estimate of 50.00 and a low estimate of 30.75. The median estimate represents a +97.49% increase from the last price of 18.74.
The current consensus among 6 polled investment analysts is to Buy stock in Anavex Life Sciences Corp. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.15
Reporting Date Dec 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.